X-154792236-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_002436.4(MPP1):c.152G>A(p.Gly51Glu) variant causes a missense change. The variant allele was found at a frequency of 0.0000504 in 1,210,343 control chromosomes in the GnomAD database, including 1 homozygotes. There are 23 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Synonymous variant affecting the same amino acid position (i.e. G51G) has been classified as Likely benign.
Frequency
Consequence
NM_002436.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000534 AC: 6AN: 112279Hom.: 0 Cov.: 23 AF XY: 0.0000581 AC XY: 2AN XY: 34429
GnomAD3 exomes AF: 0.000153 AC: 28AN: 182675Hom.: 1 AF XY: 0.000148 AC XY: 10AN XY: 67343
GnomAD4 exome AF: 0.0000510 AC: 56AN: 1098011Hom.: 1 Cov.: 30 AF XY: 0.0000578 AC XY: 21AN XY: 363377
GnomAD4 genome AF: 0.0000445 AC: 5AN: 112332Hom.: 0 Cov.: 23 AF XY: 0.0000580 AC XY: 2AN XY: 34492
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.152G>A (p.G51E) alteration is located in exon 2 (coding exon 2) of the MPP1 gene. This alteration results from a G to A substitution at nucleotide position 152, causing the glycine (G) at amino acid position 51 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at